about
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN893Outcomes in the management of atrial fibrillation: clinical trial results can apply in practiceAnticoagulation in the elderlyAnticoagulation in atrial fibrillationAnticoagulant use for prevention of stroke in a commercial population with atrial fibrillation.Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryWarfarin therapy: a review of the literature since the Fifth American College of Chest Physicians' Consensus Conference on Antithrombotic Therapy.The rapidly changing management of cardiac arrhythmias.Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry.Prevention of cardioembolic stroke.Trends in atrial fibrillation complicating acute myocardial infarctionStroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach.The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people.The risks of warfarin use in the elderly.Poor adherence to anticoagulation guidelines in patients with non-valvular atrial fibrillation treated in a tertiary cardiology unitImproving anticoagulation management in patients with atrial fibrillation.Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation.Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.Future epidemic impact of atrial fibrillation and a new interventional strategy for stroke prophylaxis.Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.Antithrombotic agents for secondary prevention of cardioembolic and noncardioembolic stroke--another viewpoint.Warfarin therapy for atrial fibrillation in the elderly.Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic.Accuracy and clinical usefulness of the near-patient testing CoaguChek S international normalised ratio monitor in rural medical practice.Stroke: secondary prevention.Association between outpatient visits following hospital discharge and readmissions among Medicare beneficiaries with atrial fibrillation and other chronic conditions.Combining value of information analysis and ethical argumentation in decisions on participation of vulnerable patients in clinical research.Time-periodic lattice of spiral pairs in excitable media.A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillation.Benefit of Warfarin in Older Persons with Atrial Fibrillation.Antithrombotic Pharmacotherapy in the Elderly: General Issues and Clinical Conundrums
P2860
Q24801915-F1446BC6-9C83-40A5-8ED5-030A244342A1Q28188553-18816977-C5CA-4D97-87D9-58CC0AF27044Q28196884-48BF4CD6-EE99-48E8-B542-12253C89819AQ28315636-671F1595-3484-4F48-BD2B-F775C44E0FD1Q33714803-27737737-0259-4A28-8F8A-B83761C2AECAQ33730859-2D00534F-7625-48D6-BB94-76D439C7770FQ33868340-E7038842-6CB0-4184-9FD7-22457C8E5B85Q33891458-5EA5D41B-D44F-4E59-8493-A37902DE24C8Q34091490-C032CC2C-0202-4362-976B-87DD9A14DB2EQ35648111-587FDC93-E4AC-4F29-8C1C-6B1506C230FCQ36045818-48897647-D924-430C-9197-903B5FB1B1BAQ36409072-D52C45C5-4ED6-4D6B-A573-BC17BF43B222Q36426713-EC44A9C2-B6E3-4FD9-ADD2-C51AD6DC5FAEQ36446904-7AAE7A1F-6772-454A-B0E7-15D5812891A8Q36801083-11AC624D-81E2-495E-B3EA-D6716B883B5DQ36801214-C14C3B1E-68BC-4816-A635-A1F3C438AFC6Q36851402-9E1AFD27-C7EA-4B15-8157-3F864E8588ECQ37457554-DA43500E-93DA-4F78-92BD-1EAF39273714Q37859753-EA92787C-A1DD-4B17-B8AF-74A44915FA44Q40469080-76E94F83-73A5-45DE-A9DF-2AF41BC41108Q43805862-1643927E-E4BB-49C3-8A62-CD83CFE314FCQ43888383-0437A1AC-40C9-4A15-8F37-0BBA89407696Q44738340-54138A04-D83E-4A06-A5AE-1AF7C638C05DQ45021411-9A8B1668-068B-4147-A9FF-3EBFD1DAC1D8Q46722175-487113EB-0B0B-4D1E-A4D6-1F89335651A1Q46742284-4CE367CD-92C6-4CEE-B50F-95B02F5B9DD4Q48103834-143DA685-AA0A-4323-A868-EA27A8686E25Q51368069-79D6F136-2E5A-4E07-BA2B-B2889E2ADA06Q53333134-E0285636-0FF2-47B9-9F81-D9783C3904B5Q53675970-F032C3E9-1B64-4733-8C7B-2FC99536CEEFQ57764364-E0F276A3-698F-4129-88C7-20E1A669421F
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Preventing stroke in patients with atrial fibrillation.
@ast
Preventing stroke in patients with atrial fibrillation.
@en
type
label
Preventing stroke in patients with atrial fibrillation.
@ast
Preventing stroke in patients with atrial fibrillation.
@en
prefLabel
Preventing stroke in patients with atrial fibrillation.
@ast
Preventing stroke in patients with atrial fibrillation.
@en
P356
P1476
Preventing stroke in patients with atrial fibrillation.
@en
P2093
J A Levine
M D Ezekowitz
P304
P356
10.1001/JAMA.281.19.1830
P407
P577
1999-05-01T00:00:00Z